Epizyme, Inc.·4

Feb 5, 4:40 PM ET

TOMBESI PAOLO 4

4 · Epizyme, Inc. · Filed Feb 5, 2021

Insider Transaction Report

Form 4
Period: 2021-02-04
TOMBESI PAOLO
Chief Financial Officer
Transactions
  • Sale

    Common Stock, par value $0.0001

    2021-02-04$11.21/sh1,021$11,44553,465 total
Footnotes (1)
  • [F1]Represents shares automatically sold by the reporting person to satisfy tax withholding obligations in connection with the vesting of the restricted stock units granted under the issuer's 2013 Stock Incentive Plan on February 3, 2020. The automatic sale of the reporting person's shares is provided for in a restricted stock unit agreement constituting a "binding contract" consistent with the affirmative defense to liability under Rule 10b5-1 and the sale does not represent a discretionary trade by the reporting person.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION